Mapping the SF-12 to preference-based instruments - Convergent validity in a low-income, minority population

被引:57
作者
Franks, P
Lubetkin, EI
Gold, MR
Tancredi, DJ
机构
[1] Univ Calif Davis, Ctr Hlth Serv Res Primary Care, Dept Family & Community Med, Sacramento, CA 95817 USA
[2] CUNY, Sch Med, Dept Community Hlth & Social Med, New York, NY 10031 USA
关键词
health status; SF-12; EQ-5D; HUI Mark 3; low-income; minority;
D O I
10.1097/01.MLR.0000093480.58308.D8
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND. The profile-based SF-12 has a low respondent burden and is used widely in clinical settings to monitor health and evaluate programs. Deriving preference scores for the SF-12 health profile would permit its use in cost-effectiveness analyses. Previous mapping studies of SF family instruments to preference-based instruments have not examined convergent validity or performance in low-income, minority populations. OBJECTIVES. To map the SF-12 to the EuroQol (EQ-5D Index) and the Health Utilities Index Mark 3 (HU13) in a low-income, predominantly minority sample. RESEARCH DESIGN. We used a cross-sectional survey data. SUBJECTS. We studied a convenience sample of 240 low-income, predominantly Latino and black patients attending a community health center in New York. MEASURES. We used separate regressions of the EQ-5D Index and HU13 onto the physical (PCS-12) and mental (MCS-12) components of the SF-12 scores as measures. RESULTS. For the EQ-513 Index regression, the adjusted variance explained was 58% (bootstrap validation 95% confidence interval [CI], 46-66). For the HU13 regression, the adjusted variance explained was 51% (bootstrap 95% CI, 39-59). The correlation coefficient between the 2 predicted measures was 0.96. The correlation of the predicted HU13 with the EQ-5D Index (0.73) and the predicted EQ-513 Index with the HU13 (0.70) exceeded that between the 2 original preference-based measures themselves (0.69). CONCLUSIONS. These pilot results suggest that the SF-12 could be successfully mapped to both the EQ-5D Index and HU13, yielding preference-based scores that demonstrate convergent validity in a low-income, minority sample.
引用
收藏
页码:1277 / 1283
页数:7
相关论文
共 30 条
[11]   Predicting quality of well-being scores from the SF-36: Results from the Beaver Dam Health Outcomes Study [J].
Fryback, DG ;
Lawrence, WF ;
Martin, PA ;
Klein, R ;
Klein, BEK .
MEDICAL DECISION MAKING, 1997, 17 (01) :1-9
[12]   Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project [J].
Gandek, B ;
Ware, JE ;
Aaronson, NK ;
Apolone, G ;
Bjorner, JB ;
Brazier, JE ;
Bullinger, M ;
Kaasa, S ;
Leplege, A ;
Prieto, L ;
Sullivan, M .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) :1171-1178
[13]  
Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO
[14]  
2-4
[15]  
Hisashige Akinori, 1998, Journal of Medical Investigation, V45, P123
[16]  
Hurst NP, 1997, BRIT J RHEUMATOL, V36, P551
[17]   Valuation of EuroQOL (EQ-5D) health states in an adult US sample [J].
Johnson, JA ;
Coons, SJ ;
Ergo, A ;
Szava-Kovats, G .
PHARMACOECONOMICS, 1998, 13 (04) :421-433
[18]   Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada [J].
Johnson, JA ;
Pickard, AS .
MEDICAL CARE, 2000, 38 (01) :115-121
[19]  
Kind P., 1996, QUALITY LIFE PHARMAC, V2, P191
[20]   Estimation of utilities for the effects of depression from the SF-12 [J].
Lenert, LA ;
Sherbourne, CD ;
Sugar, C ;
Wells, KB .
MEDICAL CARE, 2000, 38 (07) :763-770